Literature DB >> 17875039

Serum brain-derived neurotrophic factor levels in conversion disorder: Comparative study with depression.

Artuner Deveci1, Omer Aydemir, Oryal Taskin, Fatma Taneli, Aysen Esen-Danaci.   

Abstract

The aim of the present study was to compare serum brain-derived neurotrophic factor (BDNF) levels of patients with major depressive disorder (MDD) and conversion disorder (CD). Serum BDNF levels were measured in the following three groups: 15 CD patients without any comorbid diagnosis of psychiatric disorder, 24 patients with MDD, and 26 healthy subjects without any psychiatric diagnosis or psychiatric treatment. The serum BDNF level of the healthy control group (31.4 +/- 8.8 ng/mL) was statistically higher than the level of the MDD group (21.2 +/- 11.3 ng/mL) and the CD group (24.3 +/- 9.0 ng/mL; P = 0.008). This suggests that BDNF level may play a similar role in the pathophysiology of MDD and CD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17875039     DOI: 10.1111/j.1440-1819.2007.01710.x

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  7 in total

1.  Decreased serum BDNF levels in patients with epileptic and psychogenic nonepileptic seizures.

Authors:  W C LaFrance; K Leaver; E G Stopa; G D Papandonatos; A S Blum
Journal:  Neurology       Date:  2010-10-05       Impact factor: 9.910

2.  Evidence of associations between brain-derived neurotrophic factor (BDNF) serum levels and gene polymorphisms with tinnitus.

Authors:  Aysun Coskunoglu; Seda Orenay-Boyacioglu; Artuner Deveci; Mustafa Bayam; Ece Onur; Arzu Onan; Fethi S Cam
Journal:  Noise Health       Date:  2017 May-Jun       Impact factor: 0.867

3.  Autonomic, Endocrine, and Inflammation Profiles in Functional Neurological Disorder: A Systematic Review and Meta-Analysis.

Authors:  Sara Paredes-Echeverri; Julie Maggio; Indrit Bègue; Susannah Pick; Timothy R Nicholson; David L Perez
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2021-10-29       Impact factor: 2.198

Review 4.  Magnetic resonance imaging and prediction of outcome in patients with major depressive disorder.

Authors:  Glenda M MacQueen
Journal:  J Psychiatry Neurosci       Date:  2009-09       Impact factor: 6.186

Review 5.  Psychogenic Non-Epileptic Seizures; a Narrative Review.

Authors:  Ameneh Jafari; Mostafa Rezaei Tavirani; Mohsen Parvareshi Hamrah; Sanaz Ahmadi Karvigh; Haniyeh Bashi Zadeh Fakhar
Journal:  Arch Acad Emerg Med       Date:  2020-01-20

6.  Decreased Plasma BDNF Levels of Patients with Somatization Disorder.

Authors:  Nam-In Kang; Jong-Il Park; Yong-Ku Kim; Jong-Chul Yang
Journal:  Psychiatry Investig       Date:  2016-09-30       Impact factor: 2.505

7.  Early-life trauma endophenotypes and brain circuit-gene expression relationships in functional neurological (conversion) disorder.

Authors:  Ibai Diez; Anna G Larson; Vihang Nakhate; Erin C Dunn; Gregory L Fricchione; Timothy R Nicholson; Jorge Sepulcre; David L Perez
Journal:  Mol Psychiatry       Date:  2020-02-12       Impact factor: 15.992

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.